Biohaven Pharma Hldgs (NYSE:BHVN) reported its Q4 earnings results on Friday, February 25, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Also check this: Insiders Buy Around $98M Of 3 Stocks
Earnings
Biohaven Pharma Hldgs missed estimated earnings by 13.73%, reporting an EPS of $-2.32 versus an estimate of $-2.04.
Revenue was up $154.90 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.49 which was followed by a 1.47% drop in the share price the next day.
Here's a look at Biohaven Pharma Hldgs's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -2.40 | -2.74 | -2.82 | -2.97 |
| EPS Actual | -1.91 | -2.62 | -2.97 | -2.69 |
| Revenue Estimate | 128.40M | 78.13M | 40.63M | 28.23M |
| Revenue Actual | 135.74M | 92.93M | 43.82M | 35.11M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
